NCT07444710 2026-03-18Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell LymphomaNational Cancer Institute (NCI)Phase 1 Not yet recruiting16 enrolled